Education
About Us
Working with TipRanks
Follow Us
QLTY - ETF AI Analysis
Top Page
GMO U.S. Quality ETF (QLTY)
Rating:75Outperform
Price Target:―
Positive Factors
Healthy Asset Base
The fund manages a large pool of assets, suggesting solid investor interest and stability.
Recent Performance Momentum
The ETF has shown steady gains over the past month and quarter, indicating positive recent momentum.
Exposure to Leading Quality Companies
Top holdings include well-known, established U.S. companies in technology and health care, which can provide durable growth and stability.
Negative Factors
Moderately High Expense Ratio
The fund’s fee is on the higher side for an ETF, which can eat into long-term returns compared with lower-cost options.
Heavy U.S. Concentration
With almost all assets in U.S. stocks, the ETF offers little geographic diversification and is highly tied to the U.S. market.
Mixed Performance Among Top Holdings
Several major positions, including some large technology names, have shown weak year-to-date performance, which can drag on overall returns.
QLTY vs. SPDR S&P 500 ETF (SPY)
AUM3.38B
RegionNorth America
Expense Ratio0.50%
Beta0.91
IssuerGMO
Inception DateNov 13, 2023
Dividend Yield0.72%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume649,643
30 Day Avg. Volume379,879
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
47.70Price Target Upside― Downside
Rating ConsensusStrong Buy
Number of Analyst Covering36
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
QLTY Summary
The GMO U.S. Quality ETF (QLTY) invests in high-quality U.S. companies across the whole stock market, without tracking a specific index. It focuses on businesses with strong finances and steady earnings, especially in technology and health care. Well-known holdings include Microsoft, Apple, Alphabet (Google), and Johnson & Johnson. Someone might invest in QLTY to seek long-term growth and diversification through a basket of leading U.S. companies instead of picking individual stocks. A key risk is that it is heavily tilted toward tech and health care, so its price can rise and fall sharply with those sectors and the overall market.
How much will it cost me?The GMO U.S. Quality ETF (QLTY) has an expense ratio of 0.50%, meaning you’ll pay $5 per year for every $1,000 invested. This expense ratio is higher than average for ETFs because it is actively managed, focusing on selecting high-quality U.S. companies rather than tracking a broad index. Active management typically involves more research and decision-making, which increases costs.
What would affect this ETF?The GMO U.S. Quality ETF (QLTY) could benefit from continued growth in the technology and healthcare sectors, which make up a significant portion of its holdings. However, rising interest rates or economic slowdowns could negatively impact the performance of high-growth companies like Microsoft, Apple, and Alphabet that dominate the fund. Regulatory changes in the U.S., particularly in tech and healthcare, may also influence the ETF's future returns.
QLTY Top 10 Holdings
QLTY is leaning hard into U.S. tech and healthcare, with a clear tilt toward AI and semiconductors. Lam Research and KLA are doing the heavy lifting, rising on strong chip demand, while Alphabet and Accenture add steady, tech-driven support. On the flip side, Apple looks like it’s losing steam, and Meta and Broadcom have been more of a drag lately, keeping overall momentum in check. Johnson & Johnson and Thermo Fisher help balance the ride, giving this all‑U.S. portfolio a defensive backbone behind its growth engines.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Microsoft | 5.64% | $190.25M | $3.07T | 0.74% | 79 Outperform | |
| Alphabet Class A | 5.55% | $187.15M | $3.85T | 76.64% | 85 Outperform | |
| Lam Research | 5.26% | $177.40M | $282.98B | 175.25% | 77 Outperform | |
| Meta Platforms | 5.03% | $169.63M | $1.70T | -6.64% | 76 Outperform | |
| Johnson & Johnson | 5.01% | $168.86M | $574.26B | 53.17% | 78 Outperform | |
| Apple | 4.69% | $158.21M | $4.02T | 15.94% | 79 Outperform | |
| Broadcom | 4.25% | $143.29M | $1.61T | 45.36% | 76 Outperform | |
| KLA | 3.99% | $134.53M | $187.55B | 93.58% | 77 Outperform | |
| Accenture | 3.75% | $126.42M | $148.20B | -39.11% | 79 Outperform | |
| Salesforce | 3.53% | $118.97M | $181.26B | -43.91% | 80 Outperform |
QLTY Technical Analysis
Positive
―
Price Trends
38.94
Positive
37.92
Positive
35.74
Positive
Market Momentum
-0.02
Positive
47.38
Neutral
47.44
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For QLTY, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 39.28, equal to the 50-day MA of 38.94, and equal to the 200-day MA of 35.74, indicating a neutral trend. The MACD of -0.02 indicates Positive momentum. The RSI at 47.38 is Neutral, neither overbought nor oversold. The STOCH value of 47.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for QLTY.
QLTY Peer Comparison
Comparison Results
Performance Comparison
QLTY
GMO U.S. Quality ETF
38.95
5.37
15.99%
CGUS
Capital Group Core Equity ETF
―
―
―
AKRE
Akre Focus ETF
―
―
―
DCOR
Dimensional US Core Equity 1 ETF
―
―
―
APUE
ActivePassive U.S. Equity ETF
―
―
―
TSPA
T. Rowe Price U.S. Equity Research ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents